• Japanese
  • Korean
  • Chinese
Cover Image

Adenomas Global Clinical Trials Review, H1, 2012

Abstract

Summary

GlobalData's clinical trial report, "Adenomas Global Clinical Trials Review, H1, 2012" provides data on the Adenomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adenomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Adenomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Adenomas Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Adenomas , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Adenomas
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Adenomas
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Adenomas Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
    • Bristol-Myers Squibb Company
    • Clinical Trial Overview of Bristol-Myers Squibb Company
    • Pfizer Inc.
    • Clinical Trial Overview of Pfizer Inc.
    • Agouron Pharmaceuticals Inc.
    • Clinical Trial Overview of Agouron Pharmaceuticals Inc.
    • Nihon Pharmaceutical Industry Co., Ltd.
    • Clinical Trial Overview of Nihon Pharmaceutical Industry Co., Ltd.
    • BTG plc
    • Clinical Trial Overview of BTG plc
    • ArQule, Inc.
    • Clinical Trial Overview of ArQule, Inc.
    • Bayer AG
    • Clinical Trial Overview of Bayer AG
    • ImClone LLC
    • Clinical Trial Overview of ImClone LLC
    • Novartis AG
    • Clinical Trial Overview of Novartis AG
    • GlaxoSmithKline plc
    • Clinical Trial Overview of GlaxoSmithKline plc
    • Amgen Inc.
    • Clinical Trial Overview of Amgen Inc.
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals
    • Mayo Clinic
    • Clinical Trial Overview of Mayo Clinic
    • Fourth Military Medical University
    • Clinical Trial Overview of Fourth Military Medical University
    • Assistance Publique - Hopitaux de Paris
    • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
    • Memorial Sloan Kettering Cancer Center
    • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
    • Mid-Atlantic Oncology Program
    • Clinical Trial Overview of Mid-Atlantic Oncology Program
    • Stanford University
    • Clinical Trial Overview of Stanford University
    • H. Lee Moffitt Cancer Center & Research Institute
    • Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
    • University of California, Irvine
    • Clinical Trial Overview of University of California, Irvine
    • National Taiwan University Hospital
    • Clinical Trial Overview of National Taiwan University Hospital
    • Vanderbilt-Ingram Cancer Center
    • Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
    • Dartmouth-Hitchcock Medical Center
    • Clinical Trial Overview of Dartmouth-Hitchcock Medical Center
    • Cancer Prevention Institute of California
    • Clinical Trial Overview of Cancer Prevention Institute of California
    • Huashan Hospital
    • Clinical Trial Overview of Huashan Hospital
    • University of Pittsburgh
    • Clinical Trial Overview of University of Pittsburgh
    • The University of Texas M. D. Anderson Cancer Center
    • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
    • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
    • Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University
    • Nantes University Hospital
    • Clinical Trial Overview of Nantes University Hospital
    • Universitaire Ziekenhuizen Leuven
    • Clinical Trial Overview of Universitaire Ziekenhuizen Leuven
    • Federal University of Sao Paulo
    • Clinical Trial Overview of Federal University of Sao Paulo
    • Cedars-Sinai Medical Center
    • Clinical Trial Overview of Cedars-Sinai Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Adenomas Therapeutics Market, Global, Clinical Trials by Zone, 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Adenomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
  • Adenomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
  • Adenomas Therapeutics Clinical Trials, North America, Top Countries, 2012*
  • Adenomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
  • Adenomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
  • Adenomas Therapeutics Clinical Trials, BRIC Countries, 2012*
  • Adenomas Therapeutics Clinical Trials, G7 Countries, 2012*
  • Adenomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Adenomas Therapeutics Clinical Trials, E7 Countries, 2012*
  • Adenomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials by Phase, 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Adenomas Therapeutics Market, Global, Suspended Clinical Trials, 2012*
  • Adenomas Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
  • Adenomas Therapeutics Market, Global, Terminated Clinical Trials, 2012*
  • Adenomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Adenomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Adenomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Adenomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Agouron Pharmaceuticals Inc., 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon Pharmaceutical Industry Co., Ltd., 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by BTG plc, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fourth Military Medical University, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mid-Atlantic Oncology Program, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Prevention Institute of California, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Huashan Hospital, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012*
  • Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012*

List of Figures

  • Adenomas Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Adenomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
  • Adenomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
  • Adenomas Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
  • Adenomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
  • Adenomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
  • Adenomas Therapeutics Clinical Trials, BRIC Countries (%), 2012*
  • Adenomas Therapeutics Clinical Trials, G7 Countries (%), 2012*
  • Adenomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Adenomas Therapeutics Clinical Trials, E7 Countries (%), 2012*
  • Adenomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
  • Adenomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Adenomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Adenomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Adenomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Adenomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • GlobalData Methodology
Show More
Pricing
Get Notified
Email me when related reports are published